{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T03:07:59Z","timestamp":1775876879880,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"crossref","award":["KL2TR000434 and 2UL1TR000433"],"award-info":[{"award-number":["KL2TR000434 and 2UL1TR000433"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008269","name":"Michigan Institute for Clinical and Health Research","doi-asserted-by":"publisher","award":["U050294"],"award-info":[{"award-number":["U050294"]}],"id":[{"id":"10.13039\/100008269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00520-019-05254-6","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T12:37:51Z","timestamp":1577968671000},"page":"4163-4172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Reporting of paclitaxel-induced peripheral neuropathy symptoms to clinicians among women with breast cancer: a qualitative study"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2708-7145","authenticated-orcid":false,"given":"Teresa M.","family":"Salgado","sequence":"first","affiliation":[]},{"given":"Caroline S.","family":"Quinn","sequence":"additional","affiliation":[]},{"given":"Emily K.","family":"Krumbach","sequence":"additional","affiliation":[]},{"given":"Iris","family":"Wenceslao","sequence":"additional","affiliation":[]},{"given":"Martha","family":"Gonzalez","sequence":"additional","affiliation":[]},{"given":"Holly L.","family":"Reed","sequence":"additional","affiliation":[]},{"given":"Jillian G.","family":"Syverson","sequence":"additional","affiliation":[]},{"given":"Rebecca S.","family":"Etz","sequence":"additional","affiliation":[]},{"given":"Kiran","family":"Vangipuram","sequence":"additional","affiliation":[]},{"given":"Melissa R.","family":"Barker","sequence":"additional","affiliation":[]},{"given":"N. Lynn","family":"Henry","sequence":"additional","affiliation":[]},{"given":"Karen B.","family":"Farris","sequence":"additional","affiliation":[]},{"given":"Daniel L.","family":"Hertz","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,1,2]]},"reference":[{"issue":"1","key":"5254_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.critrevonc.2011.04.012","volume":"82","author":"AA Argyriou","year":"2012","unstructured":"Argyriou AA, Bruna J, Marmiroli P, Cavaletti G (2012) Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Crit Rev Oncol Hematol 82(1):51\u201377","journal-title":"Crit Rev Oncol Hematol"},{"issue":"7","key":"5254_CR2","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.ctrv.2014.04.004","volume":"40","author":"NC Miltenburg","year":"2014","unstructured":"Miltenburg NC, Boogerd W (2014) Chemotherapy-induced neuropathy: a comprehensive survey. Cancer Treat Rev 40(7):872\u2013882","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"5254_CR3","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.breast.2015.05.006","volume":"24","author":"S Pereira","year":"2015","unstructured":"Pereira S, Fontes F, Sonin T, Dias T, Fragoso M, Castro-Lopes JM, Lunet N (2015) Neurological complications of breast cancer: a prospective cohort study. Breast 24(5):582\u2013587","journal-title":"Breast"},{"issue":"11","key":"5254_CR4","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.jpain.2009.04.006","volume":"10","author":"CC Reyes-Gibby","year":"2009","unstructured":"Reyes-Gibby CC, Morrow PK, Buzdar A, Shete S (2009) Chemotherapy-induced peripheral neuropathy as a predictor of neuropathic pain in breast cancer patients previously treated with paclitaxel. J Pain 10(11):1146\u20131150","journal-title":"J Pain"},{"issue":"5","key":"5254_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/ecc.12443","volume":"26","author":"MA Tanay","year":"2017","unstructured":"Tanay MA, Armes J, Ream E (2017) The experience of chemotherapy-induced peripheral neuropathy in adult cancer patients: a qualitative thematic synthesis. Eur J Cancer Care (Engl) 26(5):e12443","journal-title":"Eur J Cancer Care (Engl)"},{"key":"5254_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ejon.2018.09.003","volume":"36","author":"CW Chan","year":"2018","unstructured":"Chan CW, Cheng H, Au SK, Leung KT, Li YC, Wong KH, Molassiotis A (2018) Living with chemotherapy-induced peripheral neuropathy: uncovering the symptom experience and self-management of neuropathic symptoms among cancer survivors. Eur J Oncol Nurs 36:135\u2013141","journal-title":"Eur J Oncol Nurs"},{"issue":"5","key":"5254_CR7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/01.NNR.0000289503.22414.79","volume":"56","author":"MA Bakitas","year":"2007","unstructured":"Bakitas MA (2007) Background noise: the experience of chemotherapy-induced peripheral neuropathy. Nurs Res 56(5):323\u2013331","journal-title":"Nurs Res"},{"issue":"3","key":"5254_CR8","doi-asserted-by":"publisher","first-page":"E22","DOI":"10.1188\/10.CJON.E22-E28","volume":"14","author":"C Tofthagen","year":"2010","unstructured":"Tofthagen C (2010) Patient perceptions associated with chemotherapy-induced peripheral neuropathy. Clin J Oncol Nurs 14(3):E22\u2013E28","journal-title":"Clin J Oncol Nurs"},{"issue":"10","key":"5254_CR9","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1007\/s00520-011-1365-8","volume":"20","author":"RM Speck","year":"2012","unstructured":"Speck RM, DeMichele A, Farrar JT, Hennessy S, Mao JJ, Stineman MG, Barg FK (2012) Scope of symptoms and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer patients. Support Care Cancer 20(10):2433\u20132439","journal-title":"Support Care Cancer"},{"issue":"5","key":"5254_CR10","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/00002820-200509000-00008","volume":"28","author":"MM Boehmke","year":"2005","unstructured":"Boehmke MM, Dickerson SS (2005) Symptom, symptom experiences, and symptom distress encountered by women with breast cancer undergoing current treatment modalities. Cancer Nurs 28(5):382\u2013389","journal-title":"Cancer Nurs"},{"issue":"12","key":"5254_CR11","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","volume":"155","author":"M Seretny","year":"2014","unstructured":"Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, Colvin L, Fallon M (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain 155(12):2461\u20132470","journal-title":"Pain"},{"issue":"6","key":"5254_CR12","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/jnci\/djx259","volume":"110","author":"DL Hershman","year":"2018","unstructured":"Hershman DL, Unger JM, Crew KD, Till C, Greenlee H, Minasian LM, Moinpour CM, Lew DL, Fehrenbacher L, Wade JL 3rd, Wong SF, Fisch MJ, Lynn Henry N, Albain KS (2018) Two-year trends of taxane-induced neuropathy in women enrolled in a randomized trial of acetyl-L-carnitine (SWOG S0715). J Natl Cancer Inst 110(6):669\u2013676","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"5254_CR13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ejca.2014.11.024","volume":"51","author":"L Eckhoff","year":"2015","unstructured":"Eckhoff L, Knoop A, Jensen MB, Ewertz M (2015) Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors. Eur J Cancer 51(3):292\u2013300","journal-title":"Eur J Cancer"},{"issue":"11","key":"5254_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.12788\/jcso.0086","volume":"12","author":"A Beijers","year":"2014","unstructured":"Beijers A, Mols F, Dercksen W, Driessen C, Vreugdenhil G (2014) Chemotherapy-induced peripheral neuropathy and impact on quality of life 6 months after treatment with chemotherapy. J Community Support Oncol 12(11):401\u2013406","journal-title":"J Community Support Oncol"},{"key":"5254_CR15","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/2193-1801-3-366","volume":"3","author":"B Bhatnagar","year":"2014","unstructured":"Bhatnagar B, Gilmore S, Goloubeva O, Pelser C, Medeiros M, Chumsri S, Tkaczuk K, Edelman M, Bao T (2014) Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience. Springerplus 3:366","journal-title":"Springerplus"},{"issue":"11","key":"5254_CR16","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.ejca.2008.04.018","volume":"44","author":"S Wolf","year":"2008","unstructured":"Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C (2008) Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer 44(11):1507\u20131515","journal-title":"Eur J Cancer"},{"issue":"5","key":"5254_CR17","first-page":"1192","volume":"7","author":"L Vahdat","year":"2001","unstructured":"Vahdat L, Papadopoulos K, Lange D, Leuin S, Kaufman E, Donovan D, Frederick D, Bagiella E, Tiersten A, Nichols G, Garrett T, Savage D, Antman K, Hesdorffer CS, Balmaceda C (2001) Reduction of paclitaxel-induced peripheral neuropathy with glutamine. Clin Cancer Res 7(5):1192\u20131197","journal-title":"Clin Cancer Res"},{"key":"5254_CR18","doi-asserted-by":"crossref","unstructured":"Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, Chauhan C, Gavin P, Lavino A, Lustberg MB, Paice J, Schneider B, Smith ML, Smith T, Terstriep S, Wagner-Johnston N, Bak K, Loprinzi CL, American Society of Clinical O (2014) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 32 (18):1941\u20131967","DOI":"10.1200\/JCO.2013.54.0914"},{"issue":"5","key":"5254_CR19","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1200\/JOP.2012.000863","volume":"9","author":"RM Speck","year":"2013","unstructured":"Speck RM, Sammel MD, Farrar JT, Hennessy S, Mao JJ, Stineman MG, DeMichele A (2013) Impact of chemotherapy-induced peripheral neuropathy on treatment delivery in nonmetastatic breast cancer. J Oncol Pract 9(5):e234\u2013e240","journal-title":"J Oncol Pract"},{"issue":"1","key":"5254_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1001\/jamaoncol.2016.3000","volume":"3","author":"ES de Morree","year":"2017","unstructured":"de Morree ES, Vogelzang NJ, Petrylak DP, Budnik N, Wiechno PJ, Sternberg CN, Doner K, Bellmunt J, Burke JM, Ochoa de Olza M, Choudhury A, Gschwend JE, Kopyltsov E, Flechon A, van As N, Houede N, Barton D, Fandi A, Jungnelius U, Li S, Li JS, de Wit R (2017) Association of survival benefit with docetaxel in prostate cancer and total number of cycles administered: a post hoc analysis of the mainsail study. JAMA Oncol 3(1):68\u201375","journal-title":"JAMA Oncol"},{"key":"5254_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1471-2407-11-131","volume":"11","author":"S Loibl","year":"2011","unstructured":"Loibl S, Skacel T, Nekljudova V, Luck HJ, Schwenkglenks M, Brodowicz T, Zielinski C, von Minckwitz G (2011) Evaluating the impact of relative total dose intensity (RTDI) on patients\u2019 short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis. BMC Cancer 11:131","journal-title":"BMC Cancer"},{"issue":"8 Suppl","key":"5254_CR22","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1002\/cncr.27469","volume":"118","author":"JM Binkley","year":"2012","unstructured":"Binkley JM, Harris SR, Levangie PK, Pearl M, Guglielmino J, Kraus V, Rowden D (2012) Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer. Cancer 118(8 Suppl):2207\u20132216","journal-title":"Cancer"},{"key":"5254_CR23","unstructured":"Smith J, Osborn M (2008) Interpretive phenomenological analysis. In: Smith J (ed) Qualitative psychology: a practical guide to research methods. Sage, London"},{"issue":"15","key":"5254_CR24","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1158\/1078-0432.CCR-18-0656","volume":"24","author":"DL Hertz","year":"2018","unstructured":"Hertz DL, Kidwell KM, Vangipuram K, Li F, Pai MP, Burness M, Griggs JJ, Schott AF, Van Poznak C, Hayes DF, Lavoie Smith EM, Henry NL (2018) Paclitaxel plasma concentration after the first infusion predicts treatment-limiting peripheral neuropathy. Clin Cancer Res 24(15):3602\u20133610","journal-title":"Clin Cancer Res"},{"issue":"8","key":"5254_CR25","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.ejca.2005.02.012","volume":"41","author":"TJ Postma","year":"2005","unstructured":"Postma TJ, Aaronson NK, Heimans JJ, Muller MJ, Hildebrand JG, Delattre JY, Hoang-Xuan K, Lanteri-Minet M, Grant R, Huddart R, Moynihan C, Maher J, Lucey R (2005) The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer 41(8):1135\u20131139","journal-title":"Eur J Cancer"},{"key":"5254_CR26","unstructured":"Patton MQ (1990) Qualitative evaluation and research methods. 2nd edn. Sage, Newbury Park, CA"},{"issue":"1","key":"5254_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1108\/14439883200600005","volume":"6","author":"AM Whiteley","year":"2006","unstructured":"Whiteley AM, Whiteley J (2006) The familiarization study in qualitative research: from theory to practice. Qual Res J 6(1):69\u201385","journal-title":"Qual Res J"},{"issue":"1","key":"5254_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/1468794107085301","volume":"8","author":"GA Bowen","year":"2008","unstructured":"Bowen GA (2008) Naturalistic inquiry and the saturation concept: a research note. Qual Res 8(1):137\u2013152","journal-title":"Qual Res"},{"key":"5254_CR29","unstructured":"Jacelon CS, O'Dell KK (2005) Case and grounded theory as qualitative research methods. Urol Nurs 25 (1):49\u201352"},{"key":"5254_CR30","unstructured":"Miles MB, Huberman MA (1994) Qualitative data analysis: an expanded sourcebook, 2nd edn. Sage Publications, Inc."},{"issue":"3","key":"5254_CR31","first-page":"641","volume":"38","author":"MA Hadi","year":"2016","unstructured":"Hadi MA, Jose Closs S (2016) Ensuring rigour and trustworthiness of qualitative research in clinical pharmacy. Int J Clin Pharm 38(3):641\u2013646","journal-title":"Int J Clin Pharm"},{"issue":"7226","key":"5254_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1136\/bmj.320.7226.50","volume":"320","author":"N Mays","year":"2000","unstructured":"Mays N, Pope C (2000) Qualitative research in health care. Assessing quality in qualitative research. BMJ 320(7226):50\u201352","journal-title":"BMJ"},{"issue":"6","key":"5254_CR33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J (2007) Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 19(6):349\u2013357","journal-title":"Int J Qual Health Care"},{"issue":"11","key":"5254_CR34","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1089\/jpm.2010.0124","volume":"13","author":"C Tofthagen","year":"2010","unstructured":"Tofthagen C (2010) Surviving chemotherapy for colon cancer and living with the consequences. J Palliat Med 13(11):1389\u20131391","journal-title":"J Palliat Med"},{"issue":"8","key":"5254_CR35","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1007\/s00520-016-3179-1","volume":"24","author":"J Drott","year":"2016","unstructured":"Drott J, Starkhammar H, Kjellgren K, Bertero C (2016) The trajectory of neurotoxic side effects\u2019 impact on daily life: a qualitative study. Support Care Cancer 24(8):3455\u20133461","journal-title":"Support Care Cancer"},{"key":"5254_CR36","unstructured":"Caterinicchio RP (1979) Testing plausible path models of interpersonal trust in patient-physician treatment relationships. Soc Sci med med Psychol med Sociol 13a (1):81-99"},{"key":"5254_CR37","doi-asserted-by":"crossref","unstructured":"Street RL, Jr., Gordon HS, Ward MM, Krupat E, Kravitz RL (2005) Patient participation in medical consultations: why some patients are more involved than others. Med Care 43 (10):960\u2013969","DOI":"10.1097\/01.mlr.0000178172.40344.70"},{"issue":"4","key":"5254_CR38","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1188\/15.CJON.444-448","volume":"19","author":"HK Sanoff","year":"2015","unstructured":"Sanoff HK, Morris W, Mitcheltree AL, Wilson S, Lund JL (2015) Lack of support and information regarding long-term negative effects in survivors of rectal cancer. Clin J Oncol Nurs 19(4):444\u2013448","journal-title":"Clin J Oncol Nurs"},{"issue":"2","key":"5254_CR39","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1200\/JOP.18.00162","volume":"15","author":"ER Brauer","year":"2019","unstructured":"Brauer ER, Long EF, Melnikow J, Ravdin PM, Ganz PA (2019) Communicating risks of adjuvant chemotherapy for breast cancer: getting beyond the laundry list. J Oncol Pract 15(2):e98\u2013e109","journal-title":"J Oncol Pract"},{"issue":"1","key":"5254_CR40","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10549-017-4646-1","volume":"169","author":"L Zhang","year":"2018","unstructured":"Zhang L, Yu Q, Wu XC, Hsieh MC, Loch M, Chen VW, Fontham E, Ferguson T (2018) Impact of chemotherapy relative dose intensity on cause-specific and overall survival for stage I-III breast cancer: ER+\/PR+, HER2- vs. triple-negative. Breast Cancer Res Treat 169(1):175\u2013187","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"5254_CR41","doi-asserted-by":"publisher","first-page":"E31","DOI":"10.1188\/12.ONF.E31-E40","volume":"39","author":"JS Myers","year":"2012","unstructured":"Myers JS (2012) Chemotherapy-related cognitive impairment: the breast cancer experience. Oncol Nurs Forum 39(1):E31\u2013E40","journal-title":"Oncol Nurs Forum"},{"key":"5254_CR42","unstructured":"Ahmed S, Gotlieb WH, Erez G, Loiselle CG (2019) Pilot implementation of a person-centered e-health platform in gynecological cancer. Belong Life. https:\/\/belong.life\/implementation-of-a-person-centered-e-health-platform\/. Accessed 29 Oct 2019"},{"issue":"12","key":"5254_CR43","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/pon.3988","volume":"25","author":"MY Ho","year":"2016","unstructured":"Ho MY, McBride ML, Gotay C, Grunfeld E, Earle CC, Relova S, Tsonis M, Ruan JY, Chang JT, Cheung WY (2016) A qualitative focus group study to identify the needs of survivors of stage II and III colorectal cancer. Psychooncology 25(12):1470\u20131476","journal-title":"Psychooncology"},{"issue":"24","key":"5254_CR44","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1200\/JCO.2015.66.3658","volume":"34","author":"LA Penner","year":"2016","unstructured":"Penner LA, Dovidio JF, Gonzalez R, Albrecht TL, Chapman R, Foster T, Harper FW, Hagiwara N, Hamel LM, Shields AF, Gadgeel S, Simon MS, Griggs JJ, Eggly S (2016) The effects of oncologist implicit racial bias in racially discordant oncology interactions. J Clin Oncol 34(24):2874\u20132880","journal-title":"J Clin Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-05254-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-019-05254-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-05254-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:46:21Z","timestamp":1609461981000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-019-05254-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,2]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["5254"],"URL":"https:\/\/doi.org\/10.1007\/s00520-019-05254-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,2]]},"assertion":[{"value":"29 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Syverson owns stock in Pfizer Inc. and AbbVie Inc. Farris is a consultant and received remuneration from Quio Technologies. Henry received support to her institution for pharma-sponsored clinical trials from Abbvie, Pfizer, and Innocrin Pharmaceuticals. All other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the University of Michigan Institutional Review Board (HUM00086259 and HUM00099924) and University of Michigan Rogel Comprehensive Cancer Center (UMCCC 2014.002) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}